Literature DB >> 27105894

Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes.

Igor I Kuzin1, Stephen L Kates2,3, Yawen Ju2,4, Longze Zhang2,3, Homaira Rahimi2,5, Wojciech Wojciechowski6, Steven H Bernstein7, Richard Burack4,7, Edward M Schwarz2,3, Andrea Bottaro1.   

Abstract

A unique population of CD23(+) CD21(high) B cells in inflamed nodes (Bin) has been shown to accumulate in lymph nodes (LNs) draining inflamed joints of TNF-transgenic (TNF-tg) mice. Bin cells contribute to arthritis flare in mice by distorting node architecture and hampering lymphatic flow, but their existence in human inflamed LNs has not yet been described. Here, we report the characterization of resident B-cell populations in fresh popliteal lymph nodes (PLNs) from patients with severe lower limb diseases (non-RA) and rheumatoid arthritis (RA) patients, and from banked, cryopreserved reactive and normal human LN single cell suspension samples. Bin-like B cells were shown to be significantly increased in reactive LNs, and strikingly elevated (>30% of total) in RA samples. Histopathology and immunofluorescence analyses were consistent with B follicular hyperplasia and histological alterations in RA vs. non-RA PLNs. This is the first description of Bin-like B cells in human inflamed LNs. Consistent with published mouse data, this population appears to be associated with inflammatory arthritis and distortion of LN architecture. Further analyses are necessary to assess the role of CD23(+) CD21(hi) Bin-like B cells in RA pathogenesis and arthritic flare.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  B cells; Inflammation; Lymph nodes; Rheumatoid arthritis; TNF

Mesh:

Substances:

Year:  2016        PMID: 27105894      PMCID: PMC4942352          DOI: 10.1002/eji.201546266

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Lymph nodes in rheumatoid arthritis.

Authors:  A G MOTULSKY; S WEINBERG; O SAPHIR; E ROSENBERG
Journal:  AMA Arch Intern Med       Date:  1952-11

2.  CD23+ CD21(high) CD1d(high) B cells in inflamed lymph nodes are a locally differentiated population with increased antigen capture and activation potential.

Authors:  Safiehkhatoon Moshkani; Igor I Kuzin; Funmilola Adewale; Johan Jansson; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

3.  Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy.

Authors:  Jie Li; Igor Kuzin; Safiehkhatoon Moshkani; Steven T Proulx; Lianping Xing; Denise Skrombolas; Robert Dunn; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

4.  Rheumatoid lymphadenopathy: a morphological and immunohistochemical study.

Authors:  G M Kondratowicz; D P Symmons; P A Bacon; R A Mageed; E L Jones
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

Review 5.  B effector cells in rheumatoid arthritis and experimental arthritis.

Authors:  Alison Finnegan; Susan Ashaye; Keith M Hamel
Journal:  Autoimmunity       Date:  2012-04-19       Impact factor: 2.815

6.  Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis.

Authors:  E Toubi; A Kessel; G Slobodin; N Boulman; E Pavlotzky; D Zisman; M Rozenbaum; I Rosner
Journal:  Ann Rheum Dis       Date:  2006-12-05       Impact factor: 19.103

7.  Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow.

Authors:  Jie Li; Yawen Ju; Echoe M Bouta; Lianping Xing; Ronald W Wood; Igor Kuzin; Andrea Bottaro; Christopher T Ritchlin; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2013-01

8.  Immunocytological studies of lymph nodes in rheumatoid arthritis and malignant lymphoma.

Authors:  R F Willkens; G F Roth; G Husby; R C Williams
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

9.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  CD23(+)/CD21(hi) B-cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice.

Authors:  Jie Li; Quan Zhou; Ronald W Wood; Igor Kuzin; Andrea Bottaro; Christopher T Ritchlin; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Res Ther       Date:  2011-08-31       Impact factor: 5.156

View more
  11 in total

Review 1.  Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.

Authors:  Echoe M Bouta; Richard D Bell; Homaira Rahimi; Lianping Xing; Ronald W Wood; Clifton O Bingham; Christopher T Ritchlin; Edward M Schwarz
Journal:  Nat Rev Rheumatol       Date:  2018-01-11       Impact factor: 20.543

Review 2.  B Lymphocytes in Rheumatoid Arthritis and the Effects of Anti-TNF-α Agents on B Lymphocytes: A Review of the Literature.

Authors:  Ozlem Pala; Alain Diaz; Bonnie B Blomberg; Daniela Frasca
Journal:  Clin Ther       Date:  2018-05-23       Impact factor: 3.393

3.  Brief Report: Treatment of Tumor Necrosis Factor-Transgenic Mice With Anti-Tumor Necrosis Factor Restores Lymphatic Contractions, Repairs Lymphatic Vessels, and May Increase Monocyte/Macrophage Egress.

Authors:  Echoe M Bouta; Igor Kuzin; Karen de Mesy Bentley; Ronald W Wood; Homaira Rahimi; Rui-Cheng Ji; Christopher T Ritchlin; Andrea Bottaro; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Rheumatol       Date:  2017-04-04       Impact factor: 10.995

4.  TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21+/CD23- B Cell Follicles Is Prevented with Anti-TNF Therapy.

Authors:  Emily K Wu; Zoe I Henkes; Brion McGowan; Richard D Bell; Moises J Velez; Alexandra M Livingstone; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  J Immunol       Date:  2019-10-28       Impact factor: 5.422

5.  Relationship Between Lymph Node Volume and Pain Following Certolizumab Therapy for Rheumatoid Arthritis Flare: A Pilot Study.

Authors:  Homaira Rahimi; Gregory Dieudonne; Valeriy Kheyfits; Echoe M Bouta; Ronald W Wood; Rick Barrett; Sharon Moorehead; Edward M Schwarz; Christopher T Ritchlin
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-12-14

6.  Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors.

Authors:  Antonio Manzo; Francesca Benaglio; Barbara Vitolo; Chandra Bortolotto; Francesca Zibera; Monica Todoerti; Claudia Alpini; Serena Bugatti; Roberto Caporali; Fabrizio Calliada; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2016-10-22       Impact factor: 5.156

Review 7.  Novel Approaches and Challenges of Discovery of Exosite Modulators of a Disintegrin and Metalloprotease 10.

Authors:  Dmitriy Minond
Journal:  Front Mol Biosci       Date:  2020-05-06

8.  Ex vivo Demonstration of Functional Deficiencies in Popliteal Lymphatic Vessels From TNF-Transgenic Mice With Inflammatory Arthritis.

Authors:  Joshua P Scallan; Echoe M Bouta; Homaira Rahimi; H Mark Kenney; Christopher T Ritchlin; Michael J Davis; Edward M Schwarz
Journal:  Front Physiol       Date:  2021-09-27       Impact factor: 4.566

9.  Lineage tracing reveals evidence of a popliteal lymphatic muscle progenitor cell that is distinct from skeletal and vascular muscle progenitors.

Authors:  H Mark Kenney; Richard D Bell; Elysia A Masters; Lianping Xing; Christopher T Ritchlin; Edward M Schwarz
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

Review 10.  Lymph Node Stromal Cells: Mapmakers of T Cell Immunity.

Authors:  Guillaume Harlé; Camille Kowalski; Laure Garnier; Stéphanie Hugues
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.